Clinical Trial Update: Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Crofelemer for safety and efficacy in adults with Short Bowel Syndrome and intestinal failure without colon-in-continuity; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Failure
• Malabsorption Syndromes
• Short Bowel Syndrome

Drugs mentioned

• Crofelemer (crofelemer)

Snippet

Sponsor: Napo Therapeutics, S.p.A. | Conditions: Short Bowel Syndrome, Malabsorption Syndromes | Phase 2 | Status: RECRUITING